Related Experiment Video
Updated: Aug 16, 2026

Yeast As a Chassis for Developing Functional Assays to Study Human P53
Published on: August 4, 2019
MDM2 interaction with nuclear corepressor KAP1 contributes to p53 inactivation
Chuangui Wang1, Alexey Ivanov, Lihong Chen
1Molecular Oncology Program, H Lee Moffitt Comprehensive Cancer Center and Research Institute, Tampa, FL 33612, USA.
Abstract:
MDM2 is a RING domain ubiquitin E3 ligase and a major regulator of the p53 tumor suppressor. MDM2 binds to p53, inactivates p53 transcription function, inhibits p53 acetylation, and promotes p53 degradation. Here, we present evidence that MDM2 interacts with the nuclear corepressor KAP1. The binding is mediated by the N-terminal coiled-coil domain of KAP1 and the central acidic domain of MDM2. KAP1 stimulates formation of p53-HDAC1 complex and inhibits p53 acetylation by interacting with MDM2. Expression of KAP1 cooperates with MDM2 to promote p53 ubiquitination and degradation. The tumor suppressor ARF competes with KAP1 in MDM2 binding; oncogene induction of ARF expression reduces MDM2-KAP1 interaction. Depletion of endogenous KAP1 expression by RNAi stimulates p53 transcriptional activity, sensitizes p53 response to DNA damage, and increases apoptosis. Therefore, MDM2 interaction with KAP1 contributes to p53 functional regulation. ARF may regulate p53 acetylation and stability in part by inhibiting KAP1-MDM2 binding.
Insights
MDM2 interacts with KAP1, a nuclear corepressor, to regulate the p53 tumor suppressor. This interaction promotes p53 degradation, but ARF can disrupt it, stabilizing p53 and enhancing anti-cancer responses.
Area of Science:
- Molecular Biology
- Cancer Research
- Cellular Regulation
Background:
- MDM2 is a key E3 ligase regulating the p53 tumor suppressor protein.
- MDM2 controls p53 stability and function through binding, inactivation, and degradation.
- Understanding MDM2 regulation is crucial for cancer therapy.
Purpose of the Study:
- To investigate the interaction between MDM2 and the nuclear corepressor KAP1.
- To elucidate the role of the MDM2-KAP1 complex in p53 regulation.
- To explore the impact of ARF on this interaction and subsequent p53 activity.
Main Methods:
- Co-immunoprecipitation to demonstrate MDM2-KAP1 binding.
- RNA interference (RNAi) to deplete KAP1 expression.
- Analysis of p53 acetylation, ubiquitination, and transcriptional activity.
Main Results:
- MDM2 directly interacts with KAP1 via specific domains.
- KAP1 enhances MDM2-mediated p53 ubiquitination and degradation.
- ARF competes with KAP1 for MDM2 binding, reducing MDM2-KAP1 interaction.
- KAP1 depletion increases p53 activity and apoptosis.
Conclusions:
- The MDM2-KAP1 interaction is a novel mechanism for p53 functional regulation.
- KAP1 acts as a co-regulator with MDM2 to suppress p53.
- ARF's ability to disrupt KAP1-MDM2 binding offers a potential therapeutic strategy.
Related Concept Videos
Abnormal Proliferation
Negative Regulator Molecules
DNA Damage can Stall the Cell Cycle
DNA Damage Can Stall the Cell Cycle
Interactions Between Signaling Pathways
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
Inhibition of Cdk Activity

